Salomon & Ludwin’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $46.9K | Sell |
134
-1
| -0.7% | -$350 | ﹤0.01% | 273 |
|
2025
Q1 | $58.7K | Hold |
135
| – | – | 0.01% | 234 |
|
2024
Q4 | $49.8K | Sell |
135
-16
| -11% | -$5.9K | 0.01% | 245 |
|
2024
Q3 | $78.5K | Hold |
151
| – | – | 0.01% | 217 |
|
2024
Q2 | $81.8K | Sell |
151
-1,730
| -92% | -$937K | 0.01% | 213 |
|
2024
Q1 | $975K | Hold |
1,881
| – | – | 0.08% | 91 |
|
2023
Q4 | $819K | Hold |
1,881
| – | – | 0.09% | 89 |
|
2023
Q3 | $819K | Sell |
1,881
-61
| -3% | -$26.6K | 0.09% | 89 |
|
2023
Q2 | $863K | Sell |
1,942
-28
| -1% | -$12.4K | 0.09% | 82 |
|
2023
Q1 | $906K | Hold |
1,970
| – | – | 0.11% | 77 |
|
2022
Q4 | $1.01M | Buy |
1,970
+78
| +4% | +$40K | 0.13% | 74 |
|
2022
Q3 | $859K | Buy |
1,892
+1,078
| +132% | +$489K | 0.13% | 67 |
|
2022
Q2 | $393K | Buy |
814
+354
| +77% | +$171K | 0.06% | 89 |
|
2022
Q1 | $226K | Hold |
460
| – | – | 0.03% | 113 |
|
2021
Q4 | $213K | Buy |
+460
| New | +$213K | 0.03% | 105 |
|
2019
Q2 | – | Sell |
-16
| Closed | -$5K | – | 224 |
|
2019
Q1 | $5K | Buy |
+16
| New | +$5K | ﹤0.01% | 188 |
|